Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer’s disease
✍ Scribed by Victor L. Villemagne; William E. Klunk; Chester A. Mathis; Christopher C. Rowe; David J. Brooks; Bradley T. Hyman; Milos D. Ikonomovic; Kenji Ishii; Clifford R. Jack; William J. Jagust; Keith A. Johnson; Robert A. Koeppe; Val J. Lowe; Colin L. Masters; Thomas J. Montine; John C. Morris; Agneta Nordberg; Ronald C. Petersen; Eric M. Reiman; Dennis J. Selkoe; Reisa A. Sperling; Koen Van Laere; Michael W. Weiner; Alexander Drzezga
- Publisher
- Springer
- Year
- 2012
- Tongue
- English
- Weight
- 426 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To assess the safety and feasibility of prescribing long term lithium to elderly people with mild to moderate Alzheimer's disease (AD). ## Methods An open label treatment group with low dose lithium for up to 1 year with the Lithium Side Effects Rating Scale as the prima